Lacto-N-fucopentaose I

Cat. No.: IBDI-430964

Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development.

Product Details

Target	Endogenous Metabolite | CDK | Reactive Oxygen Species | Apoptosis | EnterovirusBacterial
Molecular Weight	853.77
Appearance	Solid
Synonyms	LNFP I
SMILES	CC(N[[email protected]@H]1[[email protected]]([[email protected]@H]([[email protected]@H](CO)O[[email protected]]1O[[email protected]]2([H])[[email protected]]([[email protected]@H](O[[email protected]](CO)[[email protected]@H]2O)O[[email protected]@]([[email protected]](O)CO)([H])[[email protected]](O)[[email protected]@H](O)C=O)O)O)O[[email protected]@]3([H])[[email protected]@H]([[email protected]]([[email protected]@H](O)[[email protected]@H](CO)O3)O)O[[email protected]@]4([H])[[email protected]]([[email protected]@H]([[email protected]](O)[[email protected]](C)O4)O)O)=O
Structure Classification	Saccharides>Polysaccharides

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.